SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 33.53-2.8%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nowandthen who wrote (17113)12/14/2004 3:33:40 AM
From: LarryS   of 17367
 
He said he held no shares of XOMA...but I bet he holds some shares of a competitor.

We have seen different newsletters for psoriasis sufferers posted here. Many of their contributors have tried Raptiva and all of its competitors. Anyone can read about their experiences and make up their own minds about Raptiva. And of course there has been nothing in them that even hints at a general disapproval of Raptiva by these folks in favor of one of Rativa's competitors.

Let's deal with reality. Actual Raptiva sales figures doubled from the 1st qtr to the 2nd qtr and increased another 50% during the 3rd qtr. Nothing there to indicate any trouble or problems. And we will know much more when we get this quarters sales figures released in about a month.

Though of course if you have "proof" for your ascertions feel free to post them. Not one person's view but proof of a general mood turning against Raptiva.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext